CANAAN INC (CAN)

US1347481020 - ADR

2.06  -0.26 (-11.21%)

Premarket: 2.14 +0.08 (+3.88%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to CAN. CAN was compared to 31 industry peers in the Technology Hardware, Storage & Peripherals industry. CAN scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. CAN is valied quite expensively at the moment, while it does show a decent growth rate.



Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year CAN has reported negative net income.
In the past year CAN has reported a negative cash flow from operations.
The reported net income has been mixed in the past 5 years: CAN reported negative net income in multiple years.
The reported operating cash flow has been mixed in the past 5 years: CAN reported negative operating cash flow in multiple years.

1.2 Ratios

CAN has a worse Return On Assets (-83.97%) than 90.32% of its industry peers.
The Return On Equity of CAN (-118.96%) is worse than 70.97% of its industry peers.
Industry RankSector Rank
ROA -83.97%
ROE -118.96%
ROIC N/A
ROA(3y)-12.81%
ROA(5y)-32.65%
ROE(3y)-16.7%
ROE(5y)-49.54%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

CAN does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

More info and screens

6

2. Health

2.1 Basic Checks

CAN does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for CAN has been increased compared to 1 year ago.
CAN has more shares outstanding than it did 5 years ago.
CAN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

CAN has an Altman-Z score of 0.28. This is a bad value and indicates that CAN is not financially healthy and even has some risk of bankruptcy.
CAN's Altman-Z score of 0.28 is on the low side compared to the rest of the industry. CAN is outperformed by 77.42% of its industry peers.
There is no outstanding debt for CAN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 0.28
ROIC/WACCN/A
WACC11.92%

2.3 Liquidity

A Current Ratio of 2.69 indicates that CAN has no problem at all paying its short term obligations.
CAN's Current ratio of 2.69 is fine compared to the rest of the industry. CAN outperforms 74.19% of its industry peers.
CAN has a Quick Ratio of 1.64. This is a normal value and indicates that CAN is financially healthy and should not expect problems in meeting its short term obligations.
With a decent Quick ratio value of 1.64, CAN is doing good in the industry, outperforming 67.74% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.69
Quick Ratio 1.64

More info and screens

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 31.72% over the past year.
CAN shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -67.51%.
CAN shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -12.36% yearly.
EPS 1Y (TTM)31.72%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%42.55%
Revenue 1Y (TTM)-67.51%
Revenue growth 3Y48.25%
Revenue growth 5Y-12.36%
Sales Q2Q%120.92%

3.2 Future

Based on estimates for the next years, CAN will show a very strong growth in Earnings Per Share. The EPS will grow by 29.26% on average per year.
The Revenue is expected to grow by 48.71% on average over the next years. This is a very strong growth
EPS Next Y68.7%
EPS Next 2Y40.64%
EPS Next 3Y29.26%
EPS Next 5YN/A
Revenue Next Year32.71%
Revenue Next 2Y56.64%
Revenue Next 3Y48.71%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CAN. In the last year negative earnings were reported.
Also next year CAN is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

A more expensive valuation may be justified as CAN's earnings are expected to grow with 29.26% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y40.64%
EPS Next 3Y29.26%

More info and screens

0

5. Dividend

5.1 Amount

CAN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CANAAN INC

NASDAQ:CAN (12/23/2024, 8:00:01 PM)

Premarket: 2.14 +0.08 (+3.88%)

2.06

-0.26 (-11.21%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryTechnology Hardware, Storage & Peripherals
Earnings (Last)11-20 2024-11-20/bmo
Earnings (Next)N/A N/A
Inst Owners20.95%
Inst Owner Change-7.19%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap592.74M
Analysts80
Price Target2.63 (27.67%)
Short Float %8.44%
Short Ratio1.43
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-126.4%
Min EPS beat(2)-186.61%
Max EPS beat(2)-66.2%
EPS beat(4)0
Avg EPS beat(4)-109.18%
Min EPS beat(4)-186.61%
Max EPS beat(4)-66.2%
EPS beat(8)2
Avg EPS beat(8)-47.5%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)25.43%
Min Revenue beat(2)8.9%
Max Revenue beat(2)41.96%
Revenue beat(4)2
Avg Revenue beat(4)4.46%
Min Revenue beat(4)-18.75%
Max Revenue beat(4)41.96%
Revenue beat(8)4
Avg Revenue beat(8)67.44%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)4.06%
PT rev (3m)-13.89%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)-78.15%
EPS NY rev (3m)-1225%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0.72%
Revenue NY rev (3m)-1.48%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.8
P/FCF N/A
P/OCF N/A
P/B 1.7
P/tB 1.85
EV/EBITDA N/A
EPS(TTM)-0.99
EYN/A
EPS(NY)-0.04
Fwd EYN/A
FCF(TTM)-0.44
FCFYN/A
OCF(TTM)-0.43
OCFYN/A
SpS0.74
BVpS1.21
TBVpS1.11
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -83.97%
ROE -118.96%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-12.81%
ROA(5y)-32.65%
ROE(3y)-16.7%
ROE(5y)-49.54%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0.43
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 5.55%
Cap/Sales 1.57%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.69
Quick Ratio 1.64
Altman-Z 0.28
F-Score2
WACC11.92%
ROIC/WACCN/A
Cap/Depr(3y)129.57%
Cap/Depr(5y)93.27%
Cap/Sales(3y)1.49%
Cap/Sales(5y)1.11%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)31.72%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%42.55%
EPS Next Y68.7%
EPS Next 2Y40.64%
EPS Next 3Y29.26%
EPS Next 5YN/A
Revenue 1Y (TTM)-67.51%
Revenue growth 3Y48.25%
Revenue growth 5Y-12.36%
Sales Q2Q%120.92%
Revenue Next Year32.71%
Revenue Next 2Y56.64%
Revenue Next 3Y48.71%
Revenue Next 5YN/A
EBIT growth 1Y-1642.29%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year62.02%
EBIT Next 3Y26.1%
EBIT Next 5YN/A
FCF growth 1Y52.34%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y50.98%
OCF growth 3YN/A
OCF growth 5YN/A